Splicing Factor 3b Subunit 1 (Spliceosome Factor SF3B1) mutations are encountered in 25% of uveal melanomas and present intermediate metastatic risk [80], with a third of the patients developing metastatic disease at 5 years from the time of diagnosis [80]. Here, SF3B1 is linked to metastatic neoplasm.